Literature DB >> 10871847

Fibroblast growth factor 2 up regulates telomerase activity in neural precursor cells.

S Haïk1, L R Gauthier, C Granotier, J M Peyrin, C S Lages, D Dormont, F D Boussin.   

Abstract

During brain development, neuronal and glial cells are generated from neural precursors on a precise schedule involving steps of proliferation, fate commitment and differentiation. We report that telomerase activity is highly expressed during embryonic murine cortical neurogenesis and early steps of gliogenesis and progressively decreases thereafter during cortex maturation to be undetectable in the normal adult brain. We evidenced neural precursor cells (NPC) as the principal telomerase-expressing cells in primary cultures from E15 mouse embryo cortices. Their differentiation either in neurons or in glial cells lead to a down regulation of telomerase activity that was directly correlated to the decrease of telomerase core protein (mTERT) mRNA synthesis. Furthermore, we show that FGF2 (fibroblast growth factor 2), one of the main regulators of CNS development, induces a dose-dependant increase of both the proliferation of NPC and telomerase activity in primary cortical cultures without affecting the mTERT mRNA synthesis compared to that of glyceraldehyde-3-phosphate dehydrogenase (mGAPDH). Finally, we evidenced that AZT (3'-azido-2', 3'-dideoxythymidine), known to inhibit telomerase activity, blocks in a dose dependant manner the FGF2-induced proliferation of NPC. Altogether, our results are in favor of an important role of telomerase activity during brain organogenesis. Oncogene (2000).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871847     DOI: 10.1038/sj.onc.1203596

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

Review 1.  Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology.

Authors:  J Fajkus; M Simícková; J Maláska
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

Review 2.  Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration.

Authors:  Rosalinda Madonna; Raffaele De Caterina; James T Willerson; Yong-Jian Geng
Journal:  Eur Heart J       Date:  2010-12-10       Impact factor: 29.983

3.  Antiretrovirals, Methamphetamine, and HIV-1 Envelope Protein gp120 Compromise Neuronal Energy Homeostasis in Association with Various Degrees of Synaptic and Neuritic Damage.

Authors:  Ana B Sanchez; Giuseppe P Varano; Cyrus M de Rozieres; Ricky Maung; Irene C Catalan; Cari C Dowling; Natalia E Sejbuk; Melanie M Hoefer; Marcus Kaul
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

4.  Safety profile of bone marrow mononuclear stem cells in the rehabilitation of patients with posttraumatic facial nerve paralysis-a novel modality (phase one trial).

Authors:  Sushil Kumar Aggarwal; Ashok Kumar Gupta; Manish Modi; Rijuneeta Gupta; Neelam Marwaha
Journal:  J Neurol Surg B Skull Base       Date:  2012-08

5.  Pharmacodynamics of telomerase inhibition and telomere shortening by noncytotoxic suramin.

Authors:  Yuebo Gan; Jie Lu; Bertrand Z Yeung; Christopher T Cottage; M Guillaume Wientjes; Jessie L-S Au
Journal:  AAPS J       Date:  2014-11-26       Impact factor: 4.009

Review 6.  Mammalian neural stem-cell renewal: nature versus nurture.

Authors:  Yvan Arsenijevic
Journal:  Mol Neurobiol       Date:  2003-02       Impact factor: 5.590

7.  Immortalization of neural precursors when telomerase is overexpressed in embryonal carcinomas and stem cells.

Authors:  Anneke E Schwob; Lilly J Nguyen; Karina F Meiri
Journal:  Mol Biol Cell       Date:  2008-02-06       Impact factor: 4.138

8.  Neural stem cells lose telomerase activity upon differentiating into astrocytes.

Authors:  T Miura; Y Katakura; K Yamamoto; N Uehara; T Tsuchiya; E H Kim; S Shirahata
Journal:  Cytotechnology       Date:  2001-07       Impact factor: 2.058

9.  AZT as a telomerase inhibitor.

Authors:  Daniel E Gomez; Romina G Armando; Daniel F Alonso
Journal:  Front Oncol       Date:  2012-09-06       Impact factor: 6.244

Review 10.  Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury.

Authors:  Nina Y Yuan; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.